BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 28, 2010
View Archived Issues
RNA-based therapeutics abrogate Ebola and Marburg virus infections in primates
Read More
NexMed and Bio-Quant present preclinical data on PrevOnco
Read More
E-6005 improves pruritus and inflammation in preclinical tests
Read More
Namisol tablet for multiple sclerosis shows promise in first-in-human trial
Read More
PLX-4032 shows promise to treat BRAF mutation-positive melanoma
Read More
Walter Chilcott acquires U.S. rights to Enablex from Novartis
Read More
New oral contraceptive Beyaz receives FDA approval
Read More
CHMP recommends approval of Tasigna in E.U. as first-line therapy for Ph+ CML
Read More
DSM and Crucell agree to expand Percivia PER.C6 joint venture
Read More
FDA approves Allergan's Ozurdex implants for noninfectious uveitis
Read More
CHMP recommends approval of TOBI Podhaler for cystic fibrosis
Read More
Rosiglitazone-containing diabetes medicines suspended in Europe, restricted in U.S.
Read More
Phenex Pharma receives financing for FXR and RORgt R&D programs
Read More
CHMP finds no causal relationship between GSK's Pandemrix vaccine and narcolepsy
Read More
MRC Technology patents novel protein kinase inhibitors
Read More
Inovio completes enrollment in Pennvax-B DNA vaccine trial
Read More
AstraZeneca's phase III zibotentan trial in CRPC does not meet primary endpoint
Read More
Boehringer Ingelheim identifies new mPGES-1 inhibitors
Read More
FDA accepts Bionovo's manufacturing plan for Menerba
Read More
Ligand Pharma claims new prostanoid DP2 receptor antagonists
Read More
Centocor Ortho Biotech seeks to expand Simponi label in rheumatoid arthritis
Read More
FDA grants priority review for Endo Pharma's NDA for crush-resistant oral oxymorphone
Read More
Takeda investigators describe new inhibitors of CDC7-related protein kinase
Read More
Wyeth's commercialization of Relistor extended in U.S.
Read More
Pfizer researchers claim novel gamma-secretase modulators
Read More
